The price of Spravato (esketamine nasal spray) varies depending on factors such as insurance coverage, pharmacy, and dosage. A typical out-of-pocket cost for a 30-day supply can range from $500 to over $2,000. [1]
How much does Spravato cost without insurance?
Without insurance, the cash price for Spravato can be significantly higher. For example, a single treatment session at a clinic might cost several hundred dollars, and a month's supply could exceed $4,000. [2]
What is the patient assistance program for Spravato?
Janssen Pharmaceuticals, the manufacturer of Spravato, offers a program called SPRAVATO® REMS Co-Pay Card. This program can help eligible commercially insured patients reduce their out-of-pocket costs, potentially bringing them down to as little as $10 per dose. [3] Patients with government-funded insurance, such as Medicare or Medicaid, are not eligible for this co-pay card. [3]
How is Spravato administered and what are the associated costs?
Spravato is administered as a nasal spray in a certified healthcare setting. The treatment typically involves an in-office monitoring period following administration. [4] The cost reflects not only the medication itself but also the professional services required for its safe and effective use in a supervised environment. [4]
What is Spravato approved to treat?
Spravato is approved for treatment-resistant depression (TRD) in adults and for depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior. [5]
How long does Spravato treatment last?
Treatment typically begins with twice-weekly administrations for the first four weeks, followed by a reduction to once weekly for another four weeks, and then a maintenance phase that may involve treatments every two weeks or less. [6] The total duration of treatment is determined by a healthcare professional based on individual patient response.
Are there alternative treatments for treatment-resistant depression?
Alternative treatments for TRD include other antidepressant medications, psychotherapy, and electroconvulsive therapy (ECT). [7] The choice of treatment depends on individual patient factors, including medical history and response to previous therapies.